Home/Hedge Fund Intelligence/Edgewise Therapeutics, Inc.
Nasdaq: EWTXStockForm 13F30 Jun 2026

Hedge funds that hold Edgewise Therapeutics, Inc. Nasdaq: EWTX

CUSIP 28036F105 · who reports it, how much, and how much it matters to them

33 of the 720 hedge fund managers we track reported shares of Edgewise Therapeutics, Inc. (Nasdaq: EWTX) on Form 13F for 30 June 2026. Between them they reported USD 1.6bn. The largest position belongs to Orbimed Advisors, at USD 631m.

Managers reporting it33of 720 we track
Value they reportUSD 1.6bnshares only, 30 Jun 2026
Funds they run370with a file on PPLI.com
Largest positionUSD 631mOrbimed Advisors
Typical weight0.0%median share of a manager's book
Heaviest weight11.7%Orbimed Advisors

Compiled from SEC Form 13F filings · Hedge Fund Intelligence, PPLI.com · updated

Form 13F is filed by the manager and covers all of its accounts, so a position here belongs to the firm, not to any one fund. Not investment advice.

13F
What this page is

A list of every manager in our coverage that reported this share at the end of the quarter, taken from the filings themselves. Short positions and options are not in it.

Who holds it

33 managers, USD 1.6bn between them

Taken from each manager's Form 13F for 30 June 2026. A manager appears here if it reported the shares themselves; positions held only through options are left out.

Every manager that reports Edgewise Therapeutics, Inc., largest position first

The bar and the percentage show how much of the manager's reported 13F book the position makes up. Each name opens that manager's largest fund on PPLI.com, where the rest of its book is listed.

#ManagerValue reportedShare of its book
1Orbimed Advisors1 fund on PPLI.comUSD 631m11.7%
2Ra Capital Management1 fund on PPLI.comUSD 341m3.0%
3Perceptive Advisors6 funds on PPLI.comUSD 178m2.7%
4Baker Bros. Advisors2 funds on PPLI.comUSD 150m0.8%
5Cormorant Asset Management1 fund on PPLI.comUSD 102m5.2%
6Braidwell12 funds on PPLI.comUSD 81m3.0%
7Artisan Partners1 fund on PPLI.comUSD 23m0.0%
8Citadel Advisors32 funds on PPLI.comUSD 19m0.0%
9Adage Capital Management1 fund on PPLI.comUSD 19m0.0%
10Sofinnova Investments1 fund on PPLI.comUSD 15m0.8%
11Schonfeld Strategic Advisors30 funds on PPLI.comUSD 10m0.0%
12Dafna Capital Management6 funds on PPLI.comUSD 9.2m1.8%
13D. E. Shaw & Co.15 funds on PPLI.comUSD 7.7m0.0%
14POINT72 Asset Management17 funds on PPLI.comUSD 4.8m0.0%
15Artia Global Partners1 fund on PPLI.comUSD 4m0.7%
16HighVista Strategies27 funds on PPLI.comUSD 3.7m0.8%
17Ally Bridge Group (Ny)3 funds on PPLI.comUSD 3.4m3.0%
18Boothbay Fund Management2 funds on PPLI.comUSD 3.4m0.0%
19Persistent Asset Partners10 funds on PPLI.comUSD 2.8m0.8%
20Tudor Investment Corporation10 funds on PPLI.comUSD 2.3m0.0%
21Two Sigma Investments35 funds on PPLI.comUSD 2m0.0%
22Aquatic Capital Management3 funds on PPLI.comUSD 1.5m0.1%
23Verdad Advisers6 funds on PPLI.comUSD 1.1m1.1%
24Brevan Howard Capital Management39 funds on PPLI.comUSD 1.1m0.0%
25Campbell & Company Investment Adviser8 funds on PPLI.comUSD 968,0000.1%
26LMR Partners2 funds on PPLI.comUSD 813,0000.0%
27J. Goldman & Co.1 fund on PPLI.comUSD 414,0000.0%
28Verition Fund Management3 funds on PPLI.comUSD 406,0000.0%
29Lion Point Capital1 fund on PPLI.comUSD 370,0001.8%
30Engineers Gate Manager1 fund on PPLI.comUSD 271,0000.0%
31Marshall Wace LLP84 funds on PPLI.comUSD 248,0000.0%
32Squarepoint Ops7 funds on PPLI.comUSD 230,0000.0%
33The Quarry1 fund on PPLI.comUSD 2,8850.0%
Next: where it matters most
Where it matters most

For Orbimed Advisors it is 11.7% of the book

A large manager can hold a great deal of a share and barely notice it. This table turns the question round and ranks managers by how much of their own book the position takes up.

#ManagerValue reportedShare of its book
1Orbimed AdvisorsUSD 631m11.7%
2Cormorant Asset ManagementUSD 102m5.2%
3BraidwellUSD 81m3.0%
4Ally Bridge Group (Ny)USD 3.4m3.0%
5Ra Capital ManagementUSD 341m3.0%
6Perceptive AdvisorsUSD 178m2.7%
7Lion Point CapitalUSD 370,0001.8%
8Dafna Capital ManagementUSD 9.2m1.8%
9Verdad AdvisersUSD 1.1m1.1%
10HighVista StrategiesUSD 3.7m0.8%
Next: how to read this
How to read this

What a 13F list can and cannot tell you

  • It is the manager's filing, not a fund's. Form 13F covers every account a firm runs. We cannot say which of its funds holds the shares.
  • It is a snapshot. The list shows the last day of the quarter. A manager may have bought or sold since, and trading inside the quarter leaves no trace.
  • It shows one side. Short positions, swaps and shares listed outside the United States are not reported, so a manager on this list may be hedged or net short.
  • It covers the managers we track. Our coverage is 720 managers of hedge and private funds. Banks, index funds and other institutions that file Form 13F are not counted here.
Next: questions
Questions

Questions about who holds Edgewise Therapeutics, Inc.

What is the ticker symbol of Edgewise Therapeutics, Inc.?

Edgewise Therapeutics, Inc. trades under the symbol EWTX on the Nasdaq. Its CUSIP, the code used on Form 13F, is 28036F105.

Which hedge funds own Edgewise Therapeutics, Inc. (Nasdaq: EWTX)?

33 of the 720 hedge fund managers PPLI.com tracks reported Edgewise Therapeutics, Inc. shares on Form 13F for 30 June 2026. The largest reported positions were held by Orbimed Advisors (USD 631m), Ra Capital Management (USD 341m), Perceptive Advisors (USD 178m), Baker Bros. Advisors (USD 150m) and Cormorant Asset Management (USD 102m).

How many hedge funds hold Edgewise Therapeutics, Inc.?

33 managers in our coverage reported it, and between them they run 370 funds with a file on PPLI.com. The count is of managers, because Form 13F is filed by the firm and not by each fund.

Which manager has the most riding on Edgewise Therapeutics, Inc.?

Orbimed Advisors, where the position was 11.7% of the reported 13F book at 30 June 2026.

Does this show who is short Edgewise Therapeutics, Inc.?

No. Form 13F reports long positions in U.S.-listed shares and options. Short positions are not disclosed in it.

Important information

Positions are taken by PPLI.com from Form 13F filings with the U.S. Securities and Exchange Commission for the quarter shown. They are reported by each manager, cover all of its accounts and may have changed since. PPLI.com has no relationship with Edgewise Therapeutics, Inc. or with the managers listed.

Nothing here is investment, tax or legal advice, a recommendation, or an offer or solicitation to buy or sell any security. To report an error, write to the editor.

Private consultation →
Step 1 of 2

Tell us about yourself

Read our Privacy Policy before submitting. Share only the information needed to describe your question; do not include medical records or account credentials.

✦Research assistant
✦PPLI.comResearch assistant
Explore PPLI questions and suitability factors
Ask a general question about PPLI, or explore the factors that affect suitability. Treat the answer as a starting point and check the linked sources.
Use the research with your own tax, legal and insurance advisers.
Preparing an answer
AI assistant. Educational information only. It does not determine eligibility or provide personal tax, legal, investment or insurance advice.